OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-8911217
  • Global Patient Engagement Solutions Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: December 2017 | Report Code: HHE-8911217

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Patient Engagement Solutions (PES) refers to an advanced mobile health technology that closely engages patients and healthcare providers such as hospitals or clinics in the treatment of patients. PES include, hardware, software and services to strategically share relevant healthcare information with patients and doctors to improve overall patient treatment experience. PES also minimizes chances of wrong treatment and lowers the duration of treatment as well as making the entire treatment process highly cost-effective. Patient Engagement is an objective of key healthcare reform efforts that include, Accountable Care Organizations (ACOs), Patient-Centered Medical Homes (PCMH) and meaningful use of the derived health information. The effective deployment of health information also need service providers such as Internet Service Providers (ISPs) to allow the patients to view the health information online, download the health information and even transmit that entire health information. Healthcare providers such as hospitals and clinics also need to deploy protected electronic messaging for safe communication with patients. Global patient engagement solutions market is expected to rise at a CAGR of 16.1% during forecast period 2016-2023. Patients are gradually expected to proactively engage with their healthcare providers through their mobile and handheld devices.

According to the Pew Research Center of U.S., as of 2016, nearly 90% of the United States adults own cell phones and approximately 58% own smartphones. Importantly, about 52% of smartphone owners and nearly 31% of cell phone owners have used their phone to search for medical or health information. From survey of approximately 2,339 U.S. residents, over a quarter of the respondents answered that they would rather prefer interacting with their healthcare providers digitally, instead of over the phone interactions or in person meetings with healthcare representatives. Deployment of precise patient engagement technology is needed for fruitful patient engagement. Mobile-driven patient portals enable patients to check test results while improving patient-provider communication. Mobile-enabled PES allow patients to check in for clinical appointments, view education materials, review their medical records, refill prescriptions from their mobile devices. Hence, PES is expected to streamline key administrative tasks such as patient reminders, scheduling appointments, patient registration while empowering patients to securely and easily connect with their healthcare providers. Further, PES is also capable of supporting enhanced population health management which is expected to be another key objective of health reform. For instance, deploying patient engagement technology such as safe texting can have positive impact on the overall patient’s health which is possible through the fact that patient continuously believes that he/she is under continued observation by the healthcare professional through the PES and thereby, recovers faster from the ailment condition. For instance, health-related studies depict that text messaging can be a supportive factor in successfully managing the chronic diseases such as diabetes and asthma. For instance, according to the National Institute of Health (NIH), the Children's Hospital of Philadelphia has completed a study in 2015 to identify whether regular text messaging and reminders helps to improve the patient’s consistency in taking medicines for asthma treatment which delivered an outcome that patients feel cared about through the text messaging service.

The growth across global PES market is primarily driven by notable investments in Healthcare Information Technology (HCIT) by stakeholders such as hospitals and clinics. According to 2016 data from Mercom Capital Group, there has been a substantial investment of approximately $1.4 billion in HCIT in the first quarter of 2016 which drives healthy patient engagement with their healthcare professionals such as doctors and hence, boost the market growth. The 2016 Mercom report on venture capital funding and mergers depicts that corporate venture and private equity capital in digital health sector and HCIT grew by 27% as against approximately $1.1 billion of investments made during the fourth quarter of 2015.

Source: OBRC Analysis.

The report on global patient engagement solutions market includes component, delivery mode, end-user, application and therapeutic area based segments.

Components include:

  • Hardware
  • Software
  • Services




Delivery modes include:

  • On-premise solutions
  • Cloud-based solutions



End-users include:

  • Patients
  • Payers
  • Providers
  • Other end users





Applications include:

  • Financial health management
  • Social and behavioral management
  • Home health management
  • Health management





 

Therapeutic areas include:

  • Chronic diseases
  • Fitness
  • Women’s health
  • Other therapeutic areas





The report scope is widely categorized on the basis of its component which include hardware, software and services.

The global patient engagement solutions market report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, Australia, RoAPAC)
  • Europe (UK, France, Germany, Spain, RoE)
  • Rest of World





North America holds the largest market revenue share in global patient engagement solutions market followed by Europe. The key factors driving market growth in North America are expanding aging population in United States and Canada’s initiative to enhance digital health measures and improve upon the overall healthcare delivery. The growing number of Accountable Care Organizations (ACOs) are acting as end-users for patient engagement platforms whereas requirement to minimize hospital readmissions and control exponentially rising healthcare expenditures are expected to be the additional drivers for enhanced adoption of PES, thereby drive the market growth. The federal mandate also focuses on effective deployment of healthcare IT in North America including, both United States and Canada. Deployment of Dossier Médical Personnel (DMP) in France, role of National Health Service (NHS) in the United Kingdom, rising demand for efficient healthcare delivery and advanced healthcare solutions in Germany and growing efforts to enhance care coordination in Rest of Europe (RoE) are expected to drive notable adoption of patient engagement solutions in the mentioned countries across Europe.

Global PES market report covers segmentation analysis of component, delivery mode, end-user, application and therapeutic area. Report further covers segments of component which includes hardware, software and services. Services sub-segment is expected to dominate the component segment driven by large number of services which are available globally for patient engagement solutions. The end-user segment further comprises of healthcare payers, healthcare providers, patients and other end users. Healthcare providers sub-segment is expected to dominate the end-user segment mainly driven by large number of healthcare providers available globally. The delivery mode segment further comprises of on-premise solutions and cloud-based solutions with on-premise solutions expected to dominate the delivery mode market segment. Whereas, cloud-based solutions is expected to be the fastest growing delivery mode market segment mainly driven by rapid adoption of highly secure cloud-based patient engagement solutions.

The major market players of the global patient engagement solutions market are:

  • Allscripts (U.S.)
  • McKesson Corporation (U.S.)
  • Athenahealth (U.S.)
  • IBM (U.S.)
  • Cerner Corporation (U.S.)
  • Others







These companies are using various strategies, such as merger & acquisition, collaboration, partnership and product launch. Whereas, product and service launch is the key strategy adopted by the companies in patient engagement solutions market.

For Instance, in April 2015, International Business Machine (IBM) launched IBM Watson Care Manager and IBM Watson Health Cloud for Life Sciences Compliance. These innovative solutions are expected to support the biomedical companies effectively introducing medical innovations in the market. Moreover, the product launch boost IBM’s product portfolio and drive the adoption of PES solutions which boost market growth.

In April 2015, Cerner Corporation introduced a CareAware device connectivity platform in the United States through which healthcare providers can distantly observe chronically ill patients in real-time and thus allowing proactive patient engagement to possibly minimize the risk of chronic disease fatality.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023
  • Report includes detailed analysis of different segments, such as component, end-user, delivery mode, application and therapeutic areas of global patient engagement solutions market.
  • Identify and understand the strengths, opportunities, challenges and threats of the global patient engagement solutions market.
  • Covers detailed analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of patient engagement solutions market.
  • Detailed analysis of various regulatory policies which are affecting the global patient engagement solutions market.






How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global patient engagement solutions market offers detailed analysis of strategic models, such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of patient engagement solutions market with extensive SCOT analysis of key companies. 

Key findings of the global patient engagement solutions market:

  • The key factor driving the growth of global patient engagement solutions market is the deployment of government regulations and efforts to promote patient-centric care .
  • North America is the largest market for global patient engagement solutions market in terms of market revenue share.
  • The healthcare providers market is the leading end-user segment.
  • Product and service launch is the key strategy adopted by the companies of the patient engagement solutions market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS AND TOP MARKET ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. GOVERNMENT REGULATIONS AND EFFORTS TO PROMOTE PATIENT-CENTRIC CARE
3.1.2. RISING INCENTIVES 
3.1.3. RISING ADOPTION OF PATIENT ENGAGEMENT SOLUTIONS 
3.1.4. NOTABLE INVESTMENTS IN HEALTHCARE INFORMATION TECHNOLOGY
3.1.5. GROWING NUMBER OF STRATEGIC INITIATIVES BETWEEN STAKEHOLDERS
3.1.6. RISING DEPLOYMENT OF MOBILE HEALTH SOLUTIONS
3.2. MARKET RESTRAINTS
3.2.1. LACK OF INFRASTRUCTURAL INVESTMENTS 
3.2.2. SAFETY OF PATIENT INFORMATION
3.2.3. LACK OF SKILLED IT PROFESSIONALS 
3.2.4. ABSENCE OF INTEROPERATIBILITY
3.3. MARKET OPPORTUNITIES
3.3.1. RISING MEDICAL TOURISM
3.3.2. EMERGING ASIAN ECONOMIES
3.3.3. CLOUD-BASED MODELS
3.3.4. WEARABLE HEALTH TECHNOLOGY
3.4.   MARKET CHALLENGES 
3.4.1. LACK OF HEALTH LITERACY
3.4.2. HIGH IMPLEMENTATION COST
 
4. MARKET SEGMENTATION 
4.1. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY COMPONENT
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL HARDWARE MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL SOFTWARE MARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.2.4.1. INTEGRATED SOFTWARE
4.1.5.2.4.2. STANDALONE SOFTWARE
4.1.5.3. GLOBAL SERVICES MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY DELIVERY MODE
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL ON-PREMISE SOLUTIONS  MARKET  
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL CLOUD-BASED SOLUTIONS MARKET 
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.2.5. KEY CONCLUSIONS
4.3. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY END-USER
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL PATIENTS MARKET
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL PAYERS MARKET
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL PROVIDERS MARKET
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.3.5. KEY CONCLUSIONS
4.3.5.4. OTHER GLOBAL END USERS MARKET
4.3.5.4.1. APPLICATION
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.4.5. KEY CONCLUSIONS
4.4. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY APPLICATION
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL FINANCIAL HEALTH MANAGEMENT MARKET
4.4.5.1.1. APPLICATION
4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.1.5. KEY CONCLUSIONS
4.4.5.2. GLOBAL SOCIAL AND BEHAVIORAL MANAGEMENT MARKET
4.4.5.2.1. APPLICATION
4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.2.5. KEY CONCLUSIONS
4.4.5.3. GLOBAL HOME HEALTH MANAGEMENT MARKET
4.4.5.3.1. APPLICATION
4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.3.5. KEY CONCLUSIONS
4.4.5.4. GLOBAL HEALTH MANAGEMENT MARKET
4.4.5.4.1. APPLICATION
4.4.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.4.4. TOP PLAYERS & KEY PRODUCTS 
4.4.5.4.5. KEY CONCLUSIONS
4.5. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY THERAPEUTIC AREA
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.4. OPPORTUNITY MATRIX
4.5.5. MARKET SEGMENTATION 
4.5.5.1. GLOBAL CHRONIC DISEASES MARKET
4.5.5.1.1. APPLICATION
4.5.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.5.5.1.5. KEY CONCLUSIONS
4.5.5.1.6. SUB-SEGMENTS
4.5.5.1.6.1. OBESITY
4.5.5.1.6.2. CARDIOVASCULAR DISEASES
4.5.5.1.6.3. DIABETES
4.5.5.1.6.4. OTHER CHRONIC DISEASES
4.5.5.2. GLOBAL FITNESS MARKET
4.5.5.2.1. APPLICATION
4.5.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.5.5.2.5. KEY CONCLUSIONS
4.5.5.3. GLOBAL WOMEN’S HEALTH MARKET
4.5.5.3.1. APPLICATION
4.5.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.3.4. TOP PLAYERS & KEY PRODUCTS 
4.5.5.3.5. KEY CONCLUSIONS
4.5.5.4. OTHER GLOBAL THERAPEUTIC AREAS MARKET
4.5.5.4.1. APPLICATION
4.5.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.4.4. TOP PLAYERS & KEY PRODUCTS 
4.5.5.4.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC. (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. ATHENAHEALTH INC. (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. CERNER CORPORATION (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS 
7.3.5. STRATEGIC ANALYSIS
7.4. GETWELLNETWORK INC. (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. IBM (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. LINCOR SOLUTIONS LTD. (U.S.)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.6.5. STRATEGIC ANALYSIS
7.7. MCKESSON CORPORATION (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.7.5. STRATEGIC ANALYSIS
7.8. MEDECISION INC. (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. ONEVIEW HEALTHCARE (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. ORION HEALTH LTD. (NEW ZEALAND)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS 
7.10.5. STRATEGIC ANALYSIS
7.11. PATIENTPOINT (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. PHYTEL INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. PLUS91
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. YOURCAREUNIVERSE INC. (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. WEIVU INC. (U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL PATIENT ENGAGEMENT SOLUTIONS  MARKET BY COMPONENT 2014-2023 ($ MILLION)
2. HARDWARE MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
3. SOFTWARE MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
4. SERVICES MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY DELIVERY MODE 2014-2023 ($ MILLION)
6. ON-PREMISE SOLUTIONS  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. CLOUD-BASED SOLUTIONS  MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET  BY END USER 2014-2023 ($ MILLION)
9. PATIENTS MARKET BY GEOGRAPHY 2014-2023  ($ MILLION)
10. PAYERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. PROVIDERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. OTHER END USERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET  BY APPLICATION 2014-2023 ($ MILLION)
14. FINANCIAL HEALTH MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. SOCIAL AND BEHAVIORAL MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. HOME HEALTH MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. HEALTH MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET  BY THERAPEUTIC AREA 2014-2023 ($ MILLION)
19. CHRONIC DISEASES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
20. FITNESS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
21. WOMEN’S HEALTH MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
22. OTHER THERAPEUTIC AREAS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
23. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
24. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
25. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
26. REST OF THE WORLD PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL HARDWARE MARKET 2014-2023 ($ MILLION)
2. GLOBAL SOFTWARE MARKET 2014-2023 ($ MILLION)
3. GLOBAL SERVICES MARKET  2014-2023 ($ MILLION)
4. GLOBAL ON-PREMISE SOLUTIONS MARKET 2014-2023 ($ MILLION)
5. GLOBAL CLOUD-BASED SOLUTIONS MARKET 2014-2023 ($ MILLION)
6. GLOBAL PATIENTS MARKET 2014-2023 ($ MILLION)
7. GLOBAL PAYERS MARKET 2014-2023 ($ MILLION)
8. GLOBAL PROVIDERS MARKET 2014-2023 ($ MILLION)
9. GLOBAL OTHER END USERS MARKET 2014-2023 ($ MILLION)
10. GLOBAL FINANCIAL HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
11. GLOBAL SOCIAL AND BEHAVIORAL MANAGEMENT MARKET 2014-2023 ($ MILLION)
12. HOME HEALTH MANAGEMENT  MARKET  2014-2023 ($ MILLION)
13. HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
14. CHRONIC DISEASES  MARKET  2014-2023 ($ MILLION)
15. FITNESS  MARKET  2014-2023 ($ MILLION)
16. WOMEN’S HEALTH MARKET 2014-2023 ($ MILLION)
17. OTHER THERAPEUTIC AREAS MARKET 2014-2023 ($ MILLION)
18. UNITED STATES (U.S.) PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
19. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
20. UNITED KINGDOM (UK) PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
21. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
22. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
23. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
24. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
25. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
26. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
27. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
28. AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
29. ROAPAC PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
30. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
31. MENA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023  ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.